Damage from ultraviolet (UV)B exposure is cumulative and proceeds via augmenting cellular oxidative stress. The present study investigates UVB-protective effects of Sargassum confusum derived fucoidans in human keratinocytes. Algae was extracted using Celluclast, and fucoidan fractions were recovered by step gradient ethanol precipitation. Refined fucoidan fractions were treated to human HaCaT keratinocytes and exposed to UVB (50 mJ cm-2). Among fucoidan fractions, SCFC4, the lowest molecular weight (MW) fraction indicated better UVB-protective effects with dose-dependent reduction of intracellular ROS levels, while recovering the cell viability. SCFC4 suppressed UVB-induced apoptotic body formation, sub-G1 cell content, and DNA damage by hindering the mitochondria-mediated apoptotic pathway. Also, SCFC4 repressed upstream mediators of UVB-induced inflammatory responses, which would impair stratum corneum hydration. The above therapeutic effects of SCFC4 could be attributed to suppression of nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK) pathways while activating nuclear factor erythroid 2-related factor 2 (Nrf2) mediated production of antioxidant enzymes. SCFC4 was identified as a fucoidan (MW ≈ 20 kDa) with a 64.64% fucose and 23.62% sulfate contents. Further analysis of shelf life, safety, and efficacy could promote SCFC4's use as a cosmetic ingredient.
Keywords: Fucoidan; Sargassum confusum; Skin hydration.
Copyright © 2018. Published by Elsevier B.V.